Targeting of dermal myofibroblasts through death receptor 5 arrests fibrosis in mouse models of scleroderma
Dermal myofibroblasts are responsible for fibrosis development in scleroderma. Here the authors show that a bioengineered recombinant human TRAIL ligand reverses established fibrosis in mouse models of scleroderma by targeting the death receptor 5 and inducing apoptosis of myofibroblasts.
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2019
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/aeaf85cf976741ac932eb66d3a30c13f |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|